Class I — Most Severe

ReBoost and ClearLife Nasal Sprays Recalled for Contamination

FreshRecall Team MediNatura New Mexico Inc. Other

This recall was posted 3 months ago. Check the FDA source for the latest status.

Class I Recall — Most Serious

This is a Class I recall — the most serious type. Products covered by this recall may cause serious health consequences or death.

Bottle Label, ReBoost Nasal Spray, 20 mL Bottle Label, ClearLife Allergy Nasal Spray, 20 mL Carton Label, ReBoost Nasal Spray, 20 mL Carton Label, ClearLife Allergy Nasal Spray, 20 mL

MediNatura New Mexico, Inc. is recalling all lots of ReBoost and ClearLife Nasal Sprays due to microbial contamination. The recall is a precautionary measure to ensure consumer safety.

Products Affected:

  • ReBoost Nasal Spray: Used for temporary relief of nasal congestion and other symptoms, packaged in a 20mL bottle within a white and yellow carton. NDC: 62795-4005-9, UPC: 787647 10186 3. All lots with expiration dates from 12/2022 to 12/2025 are included.
  • ClearLife Allergy Nasal Spray: Used for temporary relief of minor allergy symptoms, packaged in a 20mL bottle within a white and green carton. NDC: 62795-4006-9, UPC: 787647 10188 7. All lots with expiration dates from 12/2022 to 12/2025 are included.

Reason for Recall:

The products have been found to contain yeast, mold, and microbial contamination, including Achromobacter, at levels above acceptable specifications. This poses a risk of life-threatening infections, particularly for immunocompromised individuals.

Consumer Guidance:

Consumers should stop using these products immediately. Those who purchased directly from MediNatura can contact the company at [email protected] for a refund. Products bought from retailers should be returned to the place of purchase. For questions, contact MediNatura at (800) 621-7644, Monday-Friday, 8:00 AM to 5:00 PM MST.

Health Risk Information:

While no adverse events have been reported, consumers experiencing issues should contact their healthcare provider. Adverse reactions can be reported to the FDA's MedWatch program online or via mail or fax.

Where Products Were Sold

This recall affects products distributed nationwide across the United States.

Contact Information

Consumer Contact

Tags

View original FDA announcement